TranshumanismAustralia Join · 14 days free

The Transhuman Daily · EP.008 · Monday 9 November 2026

SHOW YOUR WORK.

Show your work: an AI-found quantum proof checked by software, gene-edited cells that helped 9 of 9 myositis patients early on, and online sessions that steadied anxiety in pregnancy.

The Transhuman Daily

SHOW YOUR WORK.

  1. A startup's AI found a proof for an 18-year-old quantum computing puzzle, checked by software

    Physical Superintelligence says its research system, running a non-public Anthropic model, found a proof of the Aaronson-Ambainis conjecture, open since 2008, and the Lean proof assistant accepted it. It limits quantum speedups on random inputs. A company claim; the paper isn't peer reviewed yet.

    Super intelligence Company claim; Lean-checked, not peer reviewed · PREPRINT · Physical Superintelligence, The Quantum Insider

  2. An audit found Anthropic's AI improving about twice as fast, but most of the evidence was redacted

    After 11 weeks inside Anthropic, the AI-safety group METR estimates its models made roughly two years of progress in the last year, mostly thanks to AI helping its researchers. Anthropic redacted a majority of the evidence METR found most informative, so the public must rely on METR's judgement.

    Super intelligence Independent assessment, partly redacted · THIS WEEK · METR, The Verge

The Transhuman Daily

SUPER INTELLIGENCE

  1. OpenAI says GPT-6 Cyber found 81 serious Firefox bugs, and Mozilla is shipping fixes

    OpenAI's new security model found 81 previously unknown high-severity Firefox flaws and built working exploits for 948 Linux kernel bugs, the company says. It rates the model 'Critical' for cyber risk and restricts access to approved security customers.

    Super intelligence Company announcement · COMPANY CLAIM · OpenAI, BleepingComputer

  2. DeepMind's AI agents found two weak spots in old, retired 1024-bit encryption

    Working with researchers from UC San Diego and Inria, Google DeepMind's supervised AI agents found a signature-forgery attack about 1,600x better than the best known method, by DeepMind's own estimate, and a cheaper way to factor many keys at once. Only retired 1024-bit RSA is affected; 2048-bit keys are safe.

    Super intelligence Company research; theoretical estimates · COMPANY CLAIM · OfficeChai, Crypto Briefing

  3. OpenAI tested AI agents on 100 everyday lab tasks; its best model scored 66.7%

    BioBasicsBench, built with the biotech Ligo, asks agents to read raw gels, plates and microscopy, catch errors and say when the evidence can't support a conclusion. GPT-6 Astra earned 66.7% of the credit, up from 43.8% for GPT-5.6 Sol: progress toward reliable AI lab help, with room to improve.

    Super intelligence Company benchmark · COMPANY CLAIM · OpenAI

  4. AI agents rehearse experiments in a virtual lab, then run the real robots

    University of Toronto researchers' AI agents write protocols, test them in a simulated copy of the lab and then direct the real robot arm; in one test they wrote more than 200 commands to measure nanocrystals. A preprint, not yet peer reviewed.

    Super intelligence Preprint · THIS WEEK · Nature

The Transhuman Daily

SUPER LONGEVITY

  1. Off-the-shelf gene-edited immune cells helped all 9 myositis patients in an early trial

    In CRISPR Therapeutics' phase 1 trial of zugo-cel, donor CAR-T cells that need no matching, all 9 patients with inflammatory myopathy responded and 5 of 6 with systemic sclerosis did at month 3, with no serious immune reactions so far. Company data from 21 patients; an early trial.

    Super longevity Phase 1 trial, 21 patients; company data · EARLY TRIAL · CRISPR Therapeutics (GlobeNewswire)

  2. An experimental weight-loss jab at least halved knee arthritis pain for about 2 in 3 people

    In two phase 3 trials with more than 1,000 people with knee osteoarthritis and overweight or obesity, about two-thirds on Eli Lilly's retatrutide had their pain at least halved, vs 38% on placebo, and the top dose took off about a quarter of body weight (NEJM). Not yet approved.

    Super longevity Two phase 3 trials, 1,000+ people · Northwestern University, New Atlas

  3. Engineered clean-up cells cut serious setbacks for failing livers in a tiny early trial

    In Resolution Therapeutics' EMERALD trial, 2 of 9 people with end-stage liver disease treated with their own engineered macrophages had death, a transplant or a relapse within 6 months, vs 8 of 21 in a comparison group: a 42% lower risk. Company data, not randomised.

    Super longevity Phase 1/2 trial, 9 patients; company data · THIS WEEK · Resolution Therapeutics (GlobeNewswire), Longevity.Technology

  4. 42 minutes of bright light a day went with 17% less dementia in 88,000 older adults

    In UK Biobank data analysed by Guangzhou Medical University, older adults who wore light sensors for a week and got at least 42 minutes of bright light a day had a 17% lower relative risk of dementia over about 8 years (General Psychiatry). An observational link, not proof.

    Super longevity Observational study, ~88,000 people · OBSERVATIONAL · ScienceAlert

The Transhuman Daily

SUPER WELLBEING

  1. Twelve short online sessions kept anxiety from climbing in pregnancy

    In King's College London's RELAX trial of 268 people 16-28 weeks pregnant, 12 online sessions that train a less negative reading of everyday moments lowered anxiety and depression before and after birth, compared with usual care (JAMA Network Open).

    Super wellbeing Randomised trial, 268 people · THIS WEEK · News-Medical

  2. A month of sleeping with a bedroom air filter smoothed blood sugar in prediabetes

    In an NYU Langone trial of more than 150 people with prediabetes, real HEPA filters cut fine particles by 36% and post-breakfast blood sugar by about 17%, compared with sham filters. A small, short trial presented at the American Heart Association's meeting, not yet peer reviewed.

    Super wellbeing Small randomised trial; conference result · EARLY TRIAL · NYU Langone Health (PR Newswire)

The Transhuman Daily

THE CATCH

  1. A drug cut a risky blood fat by 78%, but heart attacks didn't fall

    In the 7-year Lp(a)HORIZON trial of more than 8,300 people with heart disease, Novartis' pelacarsen lowered lipoprotein(a) by 78% but didn't change heart attacks, strokes or deaths (NEJM). 'It didn't work,' said senior author Steven Nissen. Lowering a number isn't the same as living longer.

    Super longevity Phase 3 trial, 8,300+ people · American Heart Association, TCTMD

  2. Australia's income gap in who gets subsidised therapy nearly doubled; poorer kids miss out most

    Monash University's study of 5.4 million Australians with a Mental Health Treatment Plan found the gap between the richest and poorest kids getting therapy within 3 months grew from 14 to 23 points, 2014-2023, as a child's first session rose from $44 to $90 out of pocket.

    Super wellbeing Analysis of Medicare and tax data · Medical Xpress

The Transhuman Daily

THE FRONTIER

  1. SpaceX aims to catch both halves of Starship with its tower, as soon as 13 November

    Starship Flight 15, with Booster 22 and Ship 42, is set to try the first catch of the upper stage as well as the booster, pending FAA approval. Catching both would mean every part of an orbital rocket coming back intact, Musk says: a step toward cheaper, reusable spaceflight.

    Frontier tech Announced plan · The News International

  2. Physicists made a supersolid, part crystal and part frictionless fluid, at room temperature

    A team from the University of Warsaw, Poland's Military University of Technology, IBM Research Zurich and CNRS made the quantum state with light-matter particles in a liquid-crystal cavity, no deep cooling needed (Science Advances): a step toward cheaper quantum sensors.

    Frontier tech Peer-reviewed lab experiment · THIS WEEK · ScienceAlert, University of Warsaw

  3. Six humanoid robots ran a Shanghai shop for a day; four of the six passed review

    In AGIBOT's 24-hour trial on 2-3 November, six G2 wheeled humanoids completed 1,730 tasks in a working convenience store, including 683 customer interactions and 147 coffees, the company says. Four of the six passed its final assessment.

    Frontier tech Company announcement · COMPANY CLAIM · AGIBOT (GlobeNewswire)

Transcript

Read the narration

Welcome to the Transhuman Daily, Monday edition.

Here's what happened in transhumanism in the last 24 hours.

Show your work. A startup's AI just solved an 18-year-old quantum puzzle, and software checked every step.

An audit says Anthropic's AI improves twice as fast.

The evidence? Mostly redacted.

OpenAI says its new model found 81 serious Firefox bugs, and Mozilla's already shipping fixes.

DeepMind's agents found two weak spots in old, retired encryption. Today's longer keys are safe.

OpenAI also tested AI on 100 everyday lab tasks.

Its best model scored about two-thirds.

In a Toronto preprint, AI agents rehearse experiments in a virtual lab, then run the real robots.

In an early trial, off-the-shelf gene-edited immune cells helped all nine patients with an autoimmune muscle disease.

In two big trials, Lilly's experimental jab at least halved knee arthritis pain for about two in three people.

In a tiny trial, engineered clean-up cells cut serious setbacks for failing livers by 42%.

In 88,000 older adults, 42 bright minutes a day went with 17% less dementia.

On to wellbeing. In a trial with expectant mums, twelve short online sessions kept anxiety from climbing.

In a small trial, a month of sleeping with an air filter smoothed blood sugar swings in prediabetes.

Now, the catch. A drug cut a risky blood fat by 78%. Heart attacks? Unchanged.

Here in Australia, the income gap in who gets subsidised therapy nearly doubled; poorer kids miss out most.

SpaceX aims to catch both halves of Starship with its tower, as soon as November 13.

And physicists made a supersolid, part crystal, part frictionless fluid, at room temperature.

And six humanoid robots ran a Shanghai shop for a whole day.

Four of the six passed review.

So, whether it's maths, medicine or machines, show your work. That's how we know what's real.

Every day, the curve gets a little steeper.

Check the board: the future is running early.

That was 24 hours. Tomorrow will be faster.

That's the Transhuman Daily for today.

Stay curious. See you tomorrow.

Want more? Meet us in North Sydney on November 27.

Good to know

Window: the 72 hours to 06:07 AEDT, Mon 9 Nov 2026 (the week's best). Evidence: the quantum proof is a company claim checked in Lean, not yet peer reviewed; OpenAI's, DeepMind's and AGIBOT's figures are their own; the Toronto lab agents are a preprint; zugo-cel, RTX001 and the air-filter results are small early trials; the light-and-dementia and Monash findings are observational. This week: METR's Anthropic report (5 Nov), the Toronto lab agents (5-6 Nov), RTX001 (5 Nov), the RELAX trial (4 Nov) and the room-temperature supersolid (3 Nov). Screenshots are the publishers' public pages as captured on 9 Nov 2026; copyright remains with the publishers. Every headline links to its source. The narrator is an AI voice; the visuals and music are generated for each episode. Nothing here is medical or financial advice.

EP.007 · SLEEP ON IT.EP.009 · FAST FORWARD. All episodes

Membership

Join the movement

Membership is how the movement grows. It keeps our meetups free and open to everyone, and it puts you in the room with the people building a longer, healthier, smarter future.

  • Keep the meetups free Your support keeps every monthly meetup free and open, and brings great speakers to Sydney.
  • Member deep-dives Guided tutorials and deep-dives on AI, longevity, neurotech and more, so you learn by doing.
  • Meet the builders Founders, researchers, investors and biohackers working on transhuman technology.
  • Hear it first New events, projects and opportunities across our network, before anyone else.

Not ready yet? Come to a free meetup first.

Join · 14 days freeRSVP 27 Nov